New York Oncology Hematology, P.C. (43 New Scotland Ave.) — Albany, New York

New York Oncology Hematology, P.C. (43 New Scotland Ave.) is a clinical research site located in Albany, New York, United States 12208.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology, P.C. (43 New Scotland Ave.) has participated in 1 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung.

Sponsors: Calithera Biosciences, Inc.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology, P.C. (43 New Scotland Ave.)?

New York Oncology Hematology, P.C. (43 New Scotland Ave.) has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology, P.C. (43 New Scotland Ave.) conducted?

New York Oncology Hematology, P.C. (43 New Scotland Ave.) has 1 clinical trials on record. Their work covers Non-Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung.

Is New York Oncology Hematology, P.C. (43 New Scotland Ave.) accredited by Crixeo Health?

New York Oncology Hematology, P.C. (43 New Scotland Ave.) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology, P.C. (43 New Scotland Ave.)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.